Investment Q&A

• Merck & Company Inc. (MRK $113.80)
  • $113.80 P/E (TTM): 15.92X Cap: $283.08B
  • View MRK Profile
  • View Questions on MRK
• AbCellera Biologics Inc. (ABCL $3.45)
  • $3.45 Cap: $1.03B
  • View ABCL Profile
  • View Questions on ABCL

Q: ABCL is down sharply today. Is there any news? Is it a 'buy' at this price?
With appreciation.
Ed

Upvote 0

Read Answer Asked by Ed on October 01, 2021

• DRI Healthcare Trust (DHT.U $11.68)
  • $11.68 Cap: $705M
  • View DHT.U Profile
  • View Questions on DHT.U
• DRI Healthcare Trust (DHT.UN $16.85)
  • $16.85 Cap: $966M
  • View DHT.UN Profile
  • View Questions on DHT.UN

Q: Hello team,
I have been reading positive reports on DRI Healthcare. Can you tell me the difference between DHT.U and DHT.UN and which would be the preferred investment? Do you believe it is worth taking a small position in this company at this time?
Thanks

Upvote 0

Read Answer Asked by Ken on October 01, 2021

Q: Is EDSA a good trading stock? Just an addendum to my previous question please: Is EDSA considered a long term good investment please?

Upvote 0

Read Answer Asked by Ron on October 01, 2021

• Profound Medical Corp. (PRN $7.22)
  • $7.22 Cap: $227M
  • View PRN Profile
  • View Questions on PRN

Q: I have been holding this stock since Feb 2020 and am in a loss position. Would this stock be a worthwhile hold?

Upvote 0

Read Answer Asked by Colleen on October 01, 2021

• WSP Global Inc. (WSP $217.42)
  • $217.42 P/E (TTM): 30.24X Cap: $29.90B
  • View WSP Profile
  • View Questions on WSP
  • View Reports on WSP
• TFI International Inc. (TFII $134.98)
  • $134.98 P/E (TTM): 35.65X Cap: $11.35B
  • View TFII Profile
  • View Questions on TFII
  • View Reports on TFII
• ATS Corporation (ATS $42.28)
  • $42.28 Cap: $4.28B
  • View ATS Profile
  • View Questions on ATS
  • View Reports on ATS
• Profound Medical Corp. (PRN $7.22)
  • $7.22 Cap: $227M
  • View PRN Profile
  • View Questions on PRN
• WELL Health Technologies Corp. (WELL $4.14)
  • $4.14 Cap: $1.06B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL
• Andlauer Healthcare Group Inc. Subordinate Voting Shares (AND $54.97)
  • $54.97 P/E (TTM): 31.81X Cap: $2.14B
  • View AND Profile
  • View Questions on AND
  • View Reports on AND

Q: Hi 5iresearch team
Can you please recommend 3 Canadian stocks for each of the industrial and healthcare sectors that you think will perform well in 2022?
Dividends is a bonus but not a must.
Thanks a lot for the great service.

Upvote 0

Read Answer Asked by Ahmed on September 30, 2021

Q: WHAT IS YOUR OPINION ABOUT THIS UPCOMING COMPANY. BNGO

Upvote 0

Read Answer Asked by Vinod on September 30, 2021

• Ginkgo Bioworks Holdings Inc. Class A (DNA $6.69)
  • $6.69 Cap: $401M
  • View DNA Profile
  • View Questions on DNA

Q: Please give me your opinion and analysis of DNA . Would you recommend this stock for a 2 to 3 year purchase. Cathy Wood has been an early investor and continues to buy stock now. Thanks

Upvote 0

Read Answer Asked by Ian on September 30, 2021

• Think Research Corporation (THNK $0.32)
  • View THNK Profile
  • View Questions on THNK

Q: Greetings 5i team.

Can you please give me your updated opinion on THNK?
I don't see any results for 8/23. When do they report next?
What are the numbers expected?
Do you think the recent Chartwell win will move the needle much on revenue?
I like the space they are occupying in the transition telemedicine going forward. Do you?

Many thanks.

Upvote 0

Read Answer Asked by Arthur on September 29, 2021

• Antibe Therapeutics Inc. (ATE $0.30)
  • View ATE Profile
  • View Questions on ATE

Q: Hello team,

Is it worth holding on to this biotechnology company?

Have been holding for a long time and down 75%. Don't need the money but wondering if averaging down will be a good idea, given their cash level?

Any updates since last news and the halting of their phase 3 trial in August?

Thanks as always! :)

Upvote 0

Read Answer Asked by Saeed on September 29, 2021

• AbbVie Inc. (ABBV $206.64)
  • $206.64 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Abbott Laboratories (ABT $107.91)
  • $107.91 P/E (TTM): 29.76X Cap: $188.95B
  • View ABT Profile
  • View Questions on ABT
• Bristol-Myers Squibb Company (BMY $58.46)
  • $58.46 P/E (TTM): 17.26X Cap: $120.90B
  • View BMY Profile
  • View Questions on BMY
• Johnson & Johnson (JNJ $237.80)
  • $237.80 P/E (TTM): 21.59X Cap: $571.51B
  • View JNJ Profile
  • View Questions on JNJ
• Merck & Company Inc. (MRK $113.80)
  • $113.80 P/E (TTM): 15.92X Cap: $283.08B
  • View MRK Profile
  • View Questions on MRK
• Pfizer Inc. (PFE $27.30)
  • $27.30 P/E (TTM): 20.18X Cap: $155.40B
  • View PFE Profile
  • View Questions on PFE

Q: I own Abbvie already and would like to add another company from the health care sector. What would be your next choice for a long term hold in a dividend focused portfolio? Considering maybe JNJ, PFE, BMY, AMGN, ABT, MRK.

Upvote 0

Read Answer Asked by Serei on September 29, 2021

• Skylight Health Group Inc. (SLHG)
  • View SLHG Profile
  • View Questions on SLHG

Q: Skylight Health Group Inc (TSXV:SLHG).

Stock is coming down for a while. what is the reason? Is it good time to buy?

Upvote 0

Read Answer Asked by vipin on September 28, 2021

Q: Hello, I would be interested in DVAX as a hold, thanks

Upvote 0

Read Answer Asked by Deborah on September 27, 2021

• AbbVie Inc. (ABBV $206.64)
  • $206.64 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Medtronic plc. (MDT $86.84)
  • $86.84 P/E (TTM): 24.7X Cap: $111.96B
  • View MDT Profile
  • View Questions on MDT
• Stryker Corporation (SYK $340.62)
  • $340.62 P/E (TTM): 41.46X Cap: $132.33B
  • View SYK Profile
  • View Questions on SYK
• Veeva Systems Inc. Class A (VEEV $185.47)
  • $185.47 P/E (TTM): 36.39X Cap: $30.25B
  • View VEEV Profile
  • View Questions on VEEV

Q: I am considering selling Veev or Abbv and buying Syk or Mdt. Could I have your thoughts on these companies today and which ones have the most long term promise? Would you have other suggestions in US healthcare?

Upvote 0

Read Answer Asked by Allen on September 27, 2021

• Savaria Corporation (SIS $25.36)
  • $25.36 P/E (TTM): 29.86X Cap: $5.81B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: X Div date on SIS is 9/28, If I buy tomorrow,Sep 27,do I get the Div. Txs for u usual great services & views

Upvote 0

Read Answer Asked by Peter on September 27, 2021

Q: Could you please list in order of preference your top 5 Pot Stock Selections & why.
Thanks Richard

Upvote 0

Read Answer Asked by Richard on September 24, 2021

• Knight Therapeutics Inc. (GUD $6.36)
  • $6.36 Cap: $615M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Is there a reason the share price of GUD responded so strongly to this news?
"Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America"

Is this the first agreement between GUD and Incyte?

Thanks!

Upvote 0

Read Answer Asked by Robert on September 24, 2021

• AbbVie Inc. (ABBV $206.64)
  • $206.64 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV

Q: Hi 5i Team,

How would the fact that Humira will be coming off patent in the not too distant future affect share price of Abbv going forward? Is it a buy, sell or hold now?
Cheers,
H

Upvote 0

Read Answer Asked by Harry on September 22, 2021

• Intuitive Surgical Inc. (ISRG $477.81)
  • $477.81 P/E (TTM): 61.34X Cap: $169.65B
  • View ISRG Profile
  • View Questions on ISRG
• Regeneron Pharmaceuticals Inc. (REGN $733.92)
  • $733.92 P/E (TTM): 18.3X Cap: $78.66B
  • View REGN Profile
  • View Questions on REGN
• AbbVie Inc. (ABBV $206.64)
  • $206.64 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Knight Therapeutics Inc. (GUD $6.36)
  • $6.36 Cap: $615M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD
• Guardant Health Inc. (GH $87.75)
  • $87.75 Cap: $11.44B
  • View GH Profile
  • View Questions on GH

Q: Now that Knight is no longer part of the BEPORT is 5i looking at a sector replacement and if so what is it? If not, since we are not restricted by borders, should we look to the U.S. for a sector weight?

Upvote 0

Read Answer Asked by Jeff on September 22, 2021

• SOC Telemed Inc. (TLMD)
  • View TLMD Profile
  • View Questions on TLMD

Q: What’s your prognosis for this company? Is there any value in holding any longer? I am massively down on this stock…looks like it’s going to zero. Is there any value here?

Upvote 0

Read Answer Asked by Leonard on September 21, 2021

• AbbVie Inc. (ABBV $206.64)
  • $206.64 P/E (TTM): 93.12X Cap: $368.38B
  • View ABBV Profile
  • View Questions on ABBV
• Pfizer Inc. (PFE $27.30)
  • $27.30 P/E (TTM): 20.18X Cap: $155.40B
  • View PFE Profile
  • View Questions on PFE

Q: good morning - sentiment seems to be trending against my largest US health care position ABBV. Do you think it prudent to sell and reinvest in another company such as Pfizer or another company? Taxes are not an issue. Thanks

Upvote 0

Read Answer Asked by alex on September 20, 2021